Seasoned executive to drive growth and capitalize on company and market momentum WALTHAM, Mass. (January 4, 2024) – Glytec, the only provider of cloud-based insulin management software as a service (SaaS) solutions across the continuum of care, today announced the...
The new-generation GlucoMetrics platform comes with significant enhancements that enable glycaemic management committees and hospitals to access key performance indicators, trends, and benchmarks related to glycemia treatment Insulin management software provider...
The measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians. The Centers for Medicare and Medicaid Services (CMS) have issued new quality measures for inpatient glycemic management as...
Strategic Partnerships, Product Innovation and Customer Expansion Underpin Insulin Dosing Technology Company’s Sustained Growth WALTHAM, Mass. (March 15, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today...
Glytec, a cloud-based insulin management software provider across the continuum of care, has announced a strategic partnership with Roche Diagnostics USA. This digital health collaboration combines Roche’s expertise in medical devices and IT solutions with Glytec’s...
Conference Identifies Key Strategies and Actionable Insights for Hospitals to Optimize Glycemic Management Ahead of New CMS Core Measures WALTHAM, MASS. (August 31, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of...
In 1921, Sir Frederick G. Banting, Charles H. Best and JJR Macleod discovered insulin at the University of Toronto. This innovation changed the course of history for individuals with type 1 diabetes, caregivers and others who require insulin. The 100 years that...
Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the...
New Research Published in Diabetes Care Journal Reveals 7x Mortality Risk for Non-ICU Patients with Severe Hyperglycemia After 2-3 Days, Indicating Need to Start Treatment on Admission WALTHAM, MASS. (December 15, 2020) – Glytec, the only provider of insulin...
Georgia’s largest health system is heightening the safety and efficacy of insulin therapy across its network of hospitals. Waltham, MA — Known nationally for innovative care models, WellStar Health System, in partnership with Glytec, is taking proactive measures to...
The digital therapeutics pioneer is expanding its intellectual property footprint beyond the U.S., gaining worldwide protections for its proprietary diabetes therapy management solutions. Waltham, MA — The rise in diabetes is truly a global phenomenon. The World...
Poised to address diabetes on a global scale, the company expands its intellectual property protections in the United States and abroad. WALTHAM, MA, June 29, 2017 – Glytec, the healthcare company behind a market-leading software solution for personalized diabetes...
Get in touch, we would like to hear from you!
Call by phone
(678) 294-4141
LinkedIn